| Activation of cell-specific transcription by a serine phosphatase at the site of asymmetric division L Duncan, S Alper, F Arigoni, R Losick, P Stragier Science 270 (5236), 641-644, 1995 | 295 | 1995 |
| An adenosine nucleotide switch controlling the activity of a cell type-specific transcription factor in B. subtilis S Alper, L Duncan, R Losick Cell 77 (2), 195-205, 1994 | 286 | 1994 |
| SpoIIAB is an anti-sigma factor that binds to and inhibits transcription by regulatory protein sigma F from Bacillus subtilis. L Duncan, R Losick Proceedings of the National Academy of Sciences 90 (6), 2325-2329, 1993 | 266 | 1993 |
| Control of developmental transcription factor sigma F by sporulation regulatory proteins SpoIIAA and SpoIIAB in Bacillus subtilis. R Schmidt, P Margolis, L Duncan, R Coppolecchia, CP Moran Jr, R Losick Proceedings of the National Academy of Sciences 87 (23), 9221-9225, 1990 | 226 | 1990 |
| Role of Adenosine Nucleotides in the Regulation of a Stress-response Transcription Factor inBacillus subtilis S Alper, A Dufour, DA Garsin, L Duncan, R Losick Journal of molecular biology 260 (2), 165-177, 1996 | 173 | 1996 |
| SpoIIE governs the phosphorylation state of a protein regulating transcription factor sigma F during sporulation in Bacillus subtilis. F Arigoni, L Duncan, S Alper, R Losick, P Stragier Proceedings of the National Academy of Sciences 93 (8), 3238-3242, 1996 | 150 | 1996 |
| SpoIIAA Governs the Release of the Cell-type Specific Transcription Factor σFFrom its Anti-sigma Factor SpoIIAB L Duncan, S Alper, R Losick Journal of molecular biology 260 (2), 147-164, 1996 | 149 | 1996 |
| Antimicrobial susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa isolates from United States medical centers stratified by infection type: results from the … HS Sader, M Castanheira, LR Duncan, RK Flamm Diagnostic microbiology and infectious disease 92 (1), 69-74, 2018 | 121 | 2018 |
| Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in … MA Pfaller, M Bassetti, LR Duncan, M Castanheira Journal of Antimicrobial Chemotherapy 72 (5), 1386-1395, 2017 | 88 | 2017 |
| In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in Staphylococcus aureus GT Robertson, EJ Bonventre, TB Doyle, Q Du, L Duncan, TW Morris, ... Antimicrobial agents and chemotherapy 52 (7), 2313-2323, 2008 | 79 | 2008 |
| A Novel Indole Compound That Inhibits Pseudomonas aeruginosa Growth by Targeting MreB Is a Substrate for MexAB-OprM GT Robertson, TB Doyle, Q Du, L Duncan, KE Mdluli, AS Lynch Journal of Bacteriology 189 (19), 6870-6881, 2007 | 64 | 2007 |
| In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci GT Robertson, EJ Bonventre, TB Doyle, Q Du, L Duncan, TW Morris, ... Antimicrobial agents and chemotherapy 52 (7), 2324-2334, 2008 | 63 | 2008 |
| Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015–16 MA Pfaller, RE Mendes, LR Duncan, RK Flamm, HS Sader Journal of Antimicrobial Chemotherapy 73 (10), 2748-2756, 2018 | 56 | 2018 |
| Activity of ceftolozane-tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates collected from respiratory tract specimens of hospitalized patients in the … M Castanheira, LR Duncan, RE Mendes, HS Sader, D Shortridge Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 02125-17, 2018 | 55 | 2018 |
| Evidence for common sites of contact between the antisigma factor SpoIIAB and its partners SpoIIAA and the developmental transcription factor σF in Bacillus subtilis DA Garsin, DM Paskowitz, L Duncan, R Losick Journal of molecular biology 284 (3), 557-568, 1998 | 52 | 1998 |
| The VARL Gene Family and the Evolutionary Origins of the Master Cell-Type Regulatory Gene, regA, in Volvox carteri L Duncan, I Nishii, A Harryman, S Buckley, A Howard, NR Friedman, ... Journal of molecular evolution 65, 1-11, 2007 | 51 | 2007 |
| Ceftobiprole activity against Gram-positive and-negative pathogens collected from the United States in 2006 and 2016 MA Pfaller, RK Flamm, RE Mendes, JM Streit, JI Smart, KA Hamed, ... Antimicrobial agents and chemotherapy 63 (1), 10.1128/aac. 01566-18, 2019 | 46 | 2019 |
| The kinase activity of the antisigma factor SpoIIAB is required for activation as well as inhibition of transcription factor σF during sporulation in Bacillus subtilis DA Garsin, L Duncan, DM Paskowitz, R Losick Journal of molecular biology 284 (3), 569-578, 1998 | 45 | 1998 |
| Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and-negative organisms collected from Europe (2015) MA Pfaller, RK Flamm, LR Duncan, JM Streit, M Castanheira, HS Sader Diagnostic Microbiology and Infectious Disease 91 (1), 77-84, 2018 | 43 | 2018 |
| Evaluating LC–MS/MS to measure accumulation of compounds within bacteria R Iyer, Z Ye, A Ferrari, L Duncan, MA Tanudra, H Tsao, T Wang, H Gao, ... ACS infectious diseases 4 (9), 1336-1345, 2018 | 35 | 2018 |
